Christian Thudium, PhD

Nordic Bioscience
Herlev, Denmark

Research focus on developing novel biomarkers for rheumatic diseases with a focus on biological understanding and validation of biomarkers in clinical therapeutic development

Disclosure information not submitted.

Presentation(s):

• 0029: Characterizing the Anti-fibrotic Effect of Tofacitinib in TGF-β Stimulated Fibroblast-like Synoviocytes from Patients with OA

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time